Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Suicide during the COVID-19 pandemic in Japan

View ORCID ProfileTakanao Tanaka, View ORCID ProfileShohei Okamoto
doi: https://doi.org/10.1101/2020.08.30.20184168
Takanao Tanaka
1Division of Social Science, Hong Kong University of Science and Technology, Clear Water Bay, Sai Kung, New Territories, Hong Kong ()
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Takanao Tanaka
  • For correspondence: takanao_tanaka@hotmail.co.jp
Shohei Okamoto
2Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, Japan ()
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shohei Okamoto
  • For correspondence: shohei@z2.keio.jp shohei@z2.keio.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

There is an emerging concern that the COVID-19 pandemic could harm psychological health and exacerbate suicide risk. Utilising month-level suicide records covering the entire Japanese population in 1,849 administrative units, we assessed whether suicide mortality changed during the pandemic. Employing difference-in-difference estimation, we found that monthly suicide rates declined by 12% during the initial five months (February to June 2020), which could have been mainly driven by the government’s generous subsidies, reduced working hours, and school closure. In stark contrast, monthly suicide rates increased by 13% in the second wave (July to September 2020), with the magnitude greater among females (29%) and children (49%). The adverse impact of the COVID-19 pandemic may remain, while its modifiers (e.g. government subsidies) may not be sustained for long, suggesting that suicide deaths could keep rising. Hence, effective suicide prevention, particularly among vulnerable populations, should be an important public health consideration.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Shohei Okamoto is supported by the postdoctoral fellowship of the Japan Society for the Promotion of Science (No. 20J00394) and the Murata Science Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was not requred as this research is based on secondary analysis of publicly available data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used in the paper are publicly available.

https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000140901.html

https://github.com/sokamoto-github/Suicide-during-the-Covid-19-pandemic-in-Japan

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 25, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Suicide during the COVID-19 pandemic in Japan
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Suicide during the COVID-19 pandemic in Japan
Takanao Tanaka, Shohei Okamoto
medRxiv 2020.08.30.20184168; doi: https://doi.org/10.1101/2020.08.30.20184168
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Suicide during the COVID-19 pandemic in Japan
Takanao Tanaka, Shohei Okamoto
medRxiv 2020.08.30.20184168; doi: https://doi.org/10.1101/2020.08.30.20184168

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1745)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (649)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2927)
  • Geriatric Medicine (286)
  • Health Economics (530)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (740)
  • Hematology (289)
  • HIV/AIDS (626)
  • Infectious Diseases (except HIV/AIDS) (12493)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (318)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2625)
  • Public and Global Health (5331)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)